INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
WX

Wang Xiaodong

Director, Chair, Scientific Advisory BrdCIK 0001662982

EDGAR filingsOpen in network
Disclosed transactions42
Buys / sells0 / 34
Max Insider Score31
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
19
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$2.53M
6,903 sh
Oct 27, 2026Oct 29, 2026
traded Oct 27, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    BeOne Medicines Ltd.Director, Chair, Scientific Advisory Brd · Sep 10, 2026
0
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M
—
403.4K sh
Oct 27, 2026
Oct 29, 2026
traded Oct 27, 2026
+2d
SEC FORM 4

Evidence

1
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$1.14M
31.0K sh
Oct 27, 2026Oct 29, 2026
traded Oct 27, 2026
+2dSEC FORM 4

Evidence

4
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$313K
880 sh
Oct 27, 2026Oct 29, 2026
traded Oct 27, 2026
+2dSEC FORM 4

Evidence

4
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$512K
1,440 sh
Oct 27, 2026Oct 29, 2026
traded Oct 27, 2026
+2dSEC FORM 4

Evidence

4
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$443K
1,239 sh
Oct 27, 2026Oct 29, 2026
traded Oct 27, 2026
+2dSEC FORM 4

Evidence

8
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$603K
1,681 sh
Oct 27, 2026Oct 29, 2026
traded Oct 27, 2026
+2dSEC FORM 4

Evidence

4
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$460K
1,280 sh
Oct 27, 2026Oct 29, 2026
traded Oct 27, 2026
+2dSEC FORM 4

Evidence

1
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$115K
320 sh
Oct 27, 2026Oct 29, 2026
traded Oct 27, 2026
+2dSEC FORM 4

Evidence

8
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$845K
2,331 sh
Oct 27, 2026Oct 29, 2026
traded Oct 27, 2026
+2dSEC FORM 4

Evidence

15
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$2.96M
8,148 sh
Oct 27, 2026Oct 29, 2026
traded Oct 27, 2026
+2dSEC FORM 4

Evidence

15
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$1.03M
2,841 sh
Oct 27, 2026Oct 29, 2026
traded Oct 27, 2026
+2dSEC FORM 4

Evidence

15
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$1.45M
3,965 sh
Oct 27, 2026Oct 29, 2026
traded Oct 27, 2026
+2dSEC FORM 4

Evidence

4
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
403.4K sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC FORM 4

Evidence

20
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$2.51M
7,167 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC FORM 4

Evidence

1
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$1.14M
31.0K sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC FORM 4

Evidence

20
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$3.63M
10.4K sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC FORM 4

Evidence

20
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$2.00M
5,681 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC FORM 4

Evidence

24
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$2.31M
6,558 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC FORM 4

Evidence

21
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$445K
1,260 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC FORM 4

Evidence

16
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$1.27M
3,499 sh
Sep 28, 2026Sep 30, 2026
traded Sep 28, 2026
+2dSEC FORM 4

Evidence

24
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$5.32M
14.5K sh
Sep 28, 2026Sep 30, 2026
traded Sep 28, 2026
+2dSEC FORM 4

Evidence

21
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$271K
738 sh
Sep 28, 2026Sep 30, 2026
traded Sep 28, 2026
+2dSEC FORM 4

Evidence

4
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
403.4K sh
Sep 28, 2026Sep 30, 2026
traded Sep 28, 2026
+2dSEC FORM 4

Evidence

3
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$43K
120 sh
Sep 28, 2026Sep 30, 2026
traded Sep 28, 2026
+2dSEC FORM 4

Evidence

3
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$14K
40 sh
Sep 28, 2026Sep 30, 2026
traded Sep 28, 2026
+2dSEC FORM 4

Evidence

16
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$1.24M
3,419 sh
Sep 28, 2026Sep 30, 2026
traded Sep 28, 2026
+2dSEC FORM 4

Evidence

1
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$1.14M
31.0K sh
Sep 28, 2026Sep 30, 2026
traded Sep 28, 2026
+2dSEC FORM 4

Evidence

6
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$57K
160 sh
Sep 28, 2026Sep 30, 2026
traded Sep 28, 2026
+2dSEC FORM 4

Evidence

13
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$809K
2,241 sh
Sep 28, 2026Sep 30, 2026
traded Sep 28, 2026
+2dSEC FORM 4

Evidence

16
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$1.54M
4,239 sh
Sep 28, 2026Sep 30, 2026
traded Sep 28, 2026
+2dSEC FORM 4

Evidence

13
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$749K
2,047 sh
Sep 28, 2026Sep 30, 2026
traded Sep 28, 2026
+2dSEC FORM 4

Evidence

24
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$983K
2,841 sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC FORM 4

Evidence

28
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$599K
1,721 sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC FORM 4

Evidence

20
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$408K
1,181 sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC FORM 4

Evidence

8
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$1.14M
31.0K sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC FORM 4

Evidence

27
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$2.61M
7,492 sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC FORM 4

Evidence

27
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$3.73M
10.7K sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC FORM 4

Evidence

31
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$2.30M
6,569 sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC FORM 4

Evidence

31
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$2.21M
6,278 sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC FORM 4

Evidence

7
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
403.4K sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC FORM 4

Evidence

24
WX
Wang XiaodongDirector, Chair, Scientific Advisory Brd
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$527K
1,517 sh
Sep 8, 2026Sep 10, 2026
traded Sep 8, 2026
+2dSEC FORM 4

Evidence